Influence of carrier surface fines on dry powder inhalation formulations

Drug Development and Industrial Pharmacy

Volumn 35, Issue 8, 2009, Pages 904-916

  Boshhiha, Antesar M ^a   Urbanetz, Nora A ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Dry powder inhaler; Lactose; Mannitol; Salbutamol sulfate; Surface modification; Wet decantation

Indexed keywords

INHALAC; LACTOSE; MANNITOL; PEARLITOL; SALBUTAMOL SULFATE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG FORMULATION; DRY POWDER; SURFACE PROPERTY; WATER VAPOR;

ADMINISTRATION, INHALATION; ALBUTEROL; DRUG CARRIERS; LACTOSE; MANNITOL; PARTICLE SIZE; POWDERS; SURFACE PROPERTIES;

EID: 70350672535     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040802698794     Document Type: Article

References (13)

1. Heng PW, Chan LW, Lim LT. (2000). Quantification of the surface morphologies of lactose carriers and their effect on the in vitro deposition of salbutamol sulphate. Chem Pharm Bull, 48(3):393-398
2. Timsina MP, Martin GP, Marriott C, Ganderton D, Yianneskis M. (1994). Drug delivery to the respiratory tract using dry powder inhalers. Int J Pharm, 101:1-13.
3. Iida K, Hayakawa Y, Okamoto H, Danjo K, Leuenberger H. (2004). Effect of surface layering time of lactose carrier particles on dry powder inhalation properties of salbutamol sulphate. Chem Pharm Bull, 52(3):350-353 (Pubitemid 41685536)
4. Iida K, Hayakawa Y, Okamoto H, Danjo K, Leuenberger H. (2003). Effect of surface covering of lactose carrier particles on dry powder inhalation properties of salbutamol sulphate. Chem Pharm Bull, 51(12):1455-1457 (Pubitemid 41694772)
5. Iida K, Inagaki Y, Todo H, Okamoto H, Danjo K, Leuenberger H. (2004). Effects of surface processing of lactose carrier particles on dry powder inhalation properties of salbutamol sulphate. Chem Pharm Bull, 52(8):938-942 (Pubitemid 41701867)
6. Iida K, Todo H, Okamoto H, Danjo K, Leuenberger H. (2005). Preparation of dry powder inhalation with lactose carrier particles surface-coated using a wurster fluidized bed. Chem Pharm Bull, 53(4):431-434
7. Chan LW, Lim LT, Heng PW. (2003). Immobilization of fine particles on lactose carrier by precision coating and its effect on the performance of dry powder formulations. J Pharm Sci, 92:975-984
8. Young PM, Cocconi D, Colombo P, Bettini R, Price R, Steele DF, et al. (2002). Characterization of a surface modified dry powder inhalation carrier prepared by 'particle smoothing'. J Pharm Pharmacol, 54:1339-1344
9. Ferrari F, Cocconi D, Bettini R, Giordano F, Santi P, Tobyn M, et al. (2004). The surface roughness of lactose particles can be modulated by wet-smoothing using a high-shear mixer. AAPS Pharm Sci Tech, 5(4):1-5.
10. Zeng XM, Martin GP, Marriott C, Pritchard J. (2001). Lactose as a carrier in dry powder formulations: The influence of surface characteristics on drug delivery. J Pharm Sci, 90:1424-1434
11. Islam N, Stewart P, Larson I, Hartley P. (2004). Lactose surface modification by decantation: Are drug-fine lactose ratios the key to better dispersion of salmeterol xinafoate from lactoseinteractive mixtures? Pharm Res, 21:492-499
12. Buckton G, Darcy P. (1999). Assessment of disorder in crystalline powders-A review of analytical techniques and their application. Int J Pharm, 179:141-158
13. Buckton G, Darcy P. (1995). The use of gravimetric studies to assess the degree of crystallinity of predominantly crystalline powders. Int J Pharm, 123:265-271